title: Phase II study of trimetrexate and cyclophosphamide in previously untreated patients with inoperable non-small cell lung cancer.
authors.forename: K
authors.initials: K
authors.lastname: Mattson
authors.forename: V
authors.initials: V
authors.lastname: Kinnula
authors.forename: P
authors.initials: P
authors.lastname: Maasilta
authors.forename: M
authors.initials: M
authors.lastname: Kajanti
authors.forename: A
authors.initials: A
authors.lastname: Niiranen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011799:Quinazolines / Q000008:administration & dosage; D012074:Remission Induction; D016597:Trimetrexate
chemical_list: D011799:Quinazolines; D003520:Cyclophosphamide; D016597:Trimetrexate